Lobe Sciences (Lobe Sciences) Change In Payables And Accrued Expense : $0.62 Mil (TTM As of Feb. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Lobe Sciences Change In Payables And Accrued Expense?

Lobe Sciences's Change In Payables And Accrued Expense for the quarter that ended in Feb. 2024 was $0.34 Mil. It means Lobe Sciences's Accounts Payable & Accrued Expense increased by $0.34 Mil from Nov. 2023 to Feb. 2024 .

Lobe Sciences's Change In Payables And Accrued Expense for the fiscal year that ended in Aug. 2023 was $1.13 Mil. It means Lobe Sciences's Accounts Payable & Accrued Expense increased by $1.13 Mil from Aug. 2022 to Aug. 2023 .

Lobe Sciences Change In Payables And Accrued Expense Historical Data

The historical data trend for Lobe Sciences's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences Change In Payables And Accrued Expense Chart

Lobe Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Aug19

Aug20

Aug21

Aug22

Aug23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

0.29

0.15

0.19

0.39

1.13

Lobe Sciences Quarterly Data
	Dec18	Mar19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	Aug23	Nov23	Feb24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															0.10	0.22	-	0.28	0.34

Lobe Sciences Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.62 Mil.

Lobe Sciences Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Lobe Sciences (Lobe Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (OTCPK:LOBEF) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

6YX0:Germany LOBE:Canada

Address

1199 West Hastings Street, Suite 1400, Vancouver, BC, CAN, V6E 3T5

Website

https://www.lobesciences.com

Lobe Sciences Ltd is a technology and services company that provides real estate, financial, management, IP, and branding support for the development of transformational medicine. It is working to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications.